222 related articles for article (PubMed ID: 25418270)
1. Understanding pharmaceutical polymorphic transformations I: influence of process variables and storage conditions.
Sood J; Sapra B; Bhandari S; Jindal M; Tiwary AK
Ther Deliv; 2014 Oct; 5(10):1123-42. PubMed ID: 25418270
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of drug physical form during granulation, tabletting and storage.
Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
[TBL] [Abstract][Full Text] [Related]
3. Quantification of crystalline forms in active pharmaceutical ingredient and tablets by X-ray powder diffraction.
Cooper VB; Pearce GE; Petts CR
J Pharm Pharmacol; 2003 Sep; 55(9):1323-9. PubMed ID: 14604477
[TBL] [Abstract][Full Text] [Related]
4. Rapid conversion of API hydrates to anhydrous forms in aqueous media.
Petrova RI; Peresypkin A; Mortko CJ; McKeown AE; Lee J; Williams JM
J Pharm Sci; 2009 Nov; 98(11):4111-8. PubMed ID: 19384923
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure and solid-state studies of aged samples of tienoxolol, an API designed against hypertension.
Mahé N; Do B; Nicolaï B; Rietveld IB; Barrio M; Tamarit JL; Céolin R; Guéchot C; Teulon JM
Int J Pharm; 2012 Jan; 422(1-2):47-51. PubMed ID: 22027392
[TBL] [Abstract][Full Text] [Related]
6. Quantifying crystallisation rates of amorphous pharmaceuticals with dynamic mechanical analysis (DMA).
Soutari N; Buanz AB; Gul MO; Tuleu C; Gaisford S
Int J Pharm; 2012 Feb; 423(2):335-40. PubMed ID: 22101291
[TBL] [Abstract][Full Text] [Related]
7. Understanding the glass-forming ability of active pharmaceutical ingredients for designing supersaturating dosage forms.
Kawakami K; Usui T; Hattori M
J Pharm Sci; 2012 Sep; 101(9):3239-48. PubMed ID: 22531946
[TBL] [Abstract][Full Text] [Related]
8. New technology for the investigation of water vapor sorption-induced crystallographic form transformations of chemical compounds: a water vapor sorption gravimetry-dispersive Raman spectroscopy coupling.
Feth MP; Jurascheck J; Spitzenberg M; Dillenz J; Bertele G; Stark H
J Pharm Sci; 2011 Mar; 100(3):1080-92. PubMed ID: 20740677
[TBL] [Abstract][Full Text] [Related]
9. Stability studies of anticancer agent bis(4-fluorobenzyl)trisulfide and synthesis of related substances.
Bao Y; Mo X; Xu X; He Y; Xu X; An H
J Pharm Biomed Anal; 2008 Nov; 48(3):664-71. PubMed ID: 18678459
[TBL] [Abstract][Full Text] [Related]
10. Formation, physical stability, and quantification of process-induced disorder in cryomilled samples of a model polymorphic drug.
Hu Y; Macfhionnghaile P; Caron V; Tajber L; Healy AM; Erxleben A; McArdle P
J Pharm Sci; 2013 Jan; 102(1):93-103. PubMed ID: 23047833
[TBL] [Abstract][Full Text] [Related]
11. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
12. Probing pseudopolymorphic transitions in pharmaceutical solids using Raman spectroscopy: hydration and dehydration of theophylline.
Amado AM; Nolasco MM; Ribeiro-Claro PJ
J Pharm Sci; 2007 May; 96(5):1366-79. PubMed ID: 17455358
[TBL] [Abstract][Full Text] [Related]
13. Solid state amorphization of pharmaceuticals.
Willart JF; Descamps M
Mol Pharm; 2008; 5(6):905-20. PubMed ID: 18954076
[TBL] [Abstract][Full Text] [Related]
14. Transformation of pharmaceutical compounds upon milling and comilling: the role of T(g).
Descamps M; Willart JF; Dudognon E; Caron V
J Pharm Sci; 2007 May; 96(5):1398-407. PubMed ID: 17455353
[TBL] [Abstract][Full Text] [Related]
15. An investigation into the influence of counterion on the properties of some amorphous organic salts.
Towler CS; Li T; Wikström H; Remick DM; Sanchez-Felix MV; Taylor LS
Mol Pharm; 2008; 5(6):946-55. PubMed ID: 19434850
[TBL] [Abstract][Full Text] [Related]
16. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
17. Basic Principles of Lyophilization, Part 1.
Akers MJ
Int J Pharm Compd; 2015; 19(6):471-6. PubMed ID: 26891561
[TBL] [Abstract][Full Text] [Related]
18. Role of water in the physical stability of solid dosage formulations.
Airaksinen S; Karjalainen M; Shevchenko A; Westermarck S; Leppänen E; Rantanen J; Yliruusi J
J Pharm Sci; 2005 Oct; 94(10):2147-65. PubMed ID: 16136577
[TBL] [Abstract][Full Text] [Related]
19. Integration of active pharmaceutical ingredient solid form selection and particle engineering into drug product design.
Ticehurst MD; Marziano I
J Pharm Pharmacol; 2015 Jun; 67(6):782-802. PubMed ID: 25677227
[TBL] [Abstract][Full Text] [Related]
20. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
Zeng XM; MacRitchie HB; Marriott C; Martin GP
Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]